Conferences Invivyd is attending in 2026–2027

LinkedIn invivyd.com

Invivyd is listed at 3 conferences on Tnuki's calendar in 2026–2027: IDWeek 2026 (exhibiting), ASH 2026 (exhibiting) and ASCO 2027 (exhibiting). Invivyd develops monoclonal antibody therapeutics for the prevention and treatment of infectious diseases. As of Oct 17, 2026.

ConferenceDetailsInvolvementTnuki guide
IDWeek 2026Infectious disease clinicians & microbiologistsOfficial site
Washington, DC ~12k attendees ExhibitorAs published by Infectious Diseases Society of America (with SHEA, HIVMA, PIDS and SIDP)
Booth 1743Program 1 poster
Attending
  • Principal Scientist
Attendee mix: Mostly clinical; ID physicians, pharmacists, infection preventionists and clinical microbiologists
Open the guide Search and filter attendees
ASH 2026 Annual Meeting & ExpositionHematologists & blood cancer researchersOfficial site
New Orleans, LA ~30k attendees ExhibitorAs published by American Society of Hematology
Booth 3753
Attendee mix: Mostly clinical; hematologists, KOLs, hematologic-oncology researchers, medical affairs and cell-therapy biopharma teams
Open the guide Search and filter attendees
ASCO Annual Meeting 2027World’s largest clinical oncology meetingOfficial site
Chicago, IL ~44k attendees ExhibitorAs published by American Society of Clinical Oncology
Booth 37077
Attendee mix: Mostly clinical; oncologists, KOLs, clinical researchers, medical affairs and oncology biopharma teams
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Invivyd’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Invivyd

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →